GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » TheraCryf PLC (FRA:8EV) » Definitions » Other Stockholders Equity

TheraCryf (FRA:8EV) Other Stockholders Equity : €3.05 Mil (As of Sep. 2023)


View and export this data going back to 2018. Start your Free Trial

What is TheraCryf Other Stockholders Equity?

TheraCryf's Other Stockholders Equity for the quarter that ended in Sep. 2023 was €3.05 Mil.

TheraCryf's quarterly Other Stockholders Equity declined from Sep. 2022 (€2.99 Mil) to Mar. 2023 (€2.92 Mil) but then increased from Mar. 2023 (€2.92 Mil) to Sep. 2023 (€3.05 Mil).

TheraCryf's annual Other Stockholders Equity increased from Mar. 2021 (€2.83 Mil) to Mar. 2022 (€3.06 Mil) but then declined from Mar. 2022 (€3.06 Mil) to Mar. 2023 (€2.92 Mil).


TheraCryf Other Stockholders Equity Historical Data

The historical data trend for TheraCryf's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TheraCryf Other Stockholders Equity Chart

TheraCryf Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Other Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.42 4.43 2.83 3.06 2.92

TheraCryf Semi-Annual Data
Mar13 Mar14 Mar15 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.93 3.06 2.99 2.92 3.05

TheraCryf Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity


TheraCryf Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of TheraCryf's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


TheraCryf (FRA:8EV) Business Description

Industry
Traded in Other Exchanges
Address
Congleton Road, Suite 24G13- Block 24, Alderley Park, Nether Alderley, GBR, SK10 4TG
Evgen Pharma PLC is a UK-based clinical-stage drug development company. The company is focused on the development of sulforaphane-based compounds. Its core technology is Sulforadex, which synthesis and stabilizes the naturally occurring compound sulforaphane. Geographically, the company operates only in the United Kingdom. It is engaged in the treatment of breast cancer and Subarachnoid Haemorrhage.

TheraCryf (FRA:8EV) Headlines

No Headlines